Rheumatology Research Review, Issue 76

In this issue:

How useful are the modified New York criteria in early SpA?
Chondroitin/glucosamine sulphate: no benefit in knee OA
Lesinurad + allopurinol lowers serum uric acid in gout
Switching from infliximab reference product to its biosimilar in AS
. . . and RA shows no loss of efficacy and is safe
Tocilizumab 8 mg/kg: best option after anti-TNF failure in RA?
Abatacept in seronegative undifferentiated arthritis
Belimumab improves morbidity associated with SLE
Psoriatic arthritis increases risk of CV disease

Please login below to download this issue (PDF)

Subscribe